Allscripts Healthcare Solutions (NASDAQ:MDRX) Posts Earnings Results, Beats Expectations By $0.01 EPS

Allscripts Healthcare Solutions (NASDAQ:MDRX) posted its quarterly earnings results on Thursday. The software maker reported $0.17 EPS for the quarter, beating the Zacks’ consensus estimate of $0.16 by $0.01, RTT News reports. Allscripts Healthcare Solutions had a net margin of 9.85% and a return on equity of 6.10%. The firm had revenue of $444.50 million for the quarter, compared to analysts’ expectations of $449.03 million. During the same quarter in the prior year, the company posted $0.18 earnings per share. The business’s revenue for the quarter was up .7% on a year-over-year basis.

MDRX stock traded down $0.43 on Friday, hitting $9.73. The company had a trading volume of 3,919,772 shares, compared to its average volume of 2,065,221. Allscripts Healthcare Solutions has a 12-month low of $8.54 and a 12-month high of $14.97. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.59. The company has a 50-day moving average of $10.97. The company has a market capitalization of $1.69 billion, a PE ratio of 17.69, a price-to-earnings-growth ratio of 2.07 and a beta of 1.30.

MDRX has been the topic of a number of recent analyst reports. BidaskClub cut shares of Allscripts Healthcare Solutions from a “sell” rating to a “strong sell” rating in a report on Friday. ValuEngine cut shares of Allscripts Healthcare Solutions from a “hold” rating to a “sell” rating in a report on Friday, July 26th. Cantor Fitzgerald reiterated a “hold” rating and set a $10.00 price target on shares of Allscripts Healthcare Solutions in a report on Thursday, May 2nd. Zacks Investment Research upgraded shares of Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a report on Wednesday, April 24th. Finally, Evercore ISI restated a “hold” rating and issued a $11.50 target price on shares of Allscripts Healthcare Solutions in a report on Sunday. Two analysts have rated the stock with a sell rating, seven have issued a hold rating and two have given a buy rating to the company. The stock has an average rating of “Hold” and an average price target of $12.42.



Hedge funds have recently modified their holdings of the stock. Parallel Advisors LLC purchased a new stake in Allscripts Healthcare Solutions in the second quarter worth approximately $28,000. C M Bidwell & Associates Ltd. purchased a new stake in Allscripts Healthcare Solutions in the second quarter worth approximately $34,000. Sun Life Financial INC purchased a new stake in Allscripts Healthcare Solutions in the second quarter worth approximately $41,000. ETF Managers Group LLC boosted its holdings in Allscripts Healthcare Solutions by 9.7% in the first quarter. ETF Managers Group LLC now owns 11,589 shares of the software maker’s stock worth $111,000 after purchasing an additional 1,028 shares during the last quarter. Finally, Connable Office Inc. purchased a new stake in Allscripts Healthcare Solutions in the first quarter worth approximately $114,000.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions.

Read More: What is systematic risk?

Earnings History for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.